News from sanofi A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 07, 2021, 07:00 ET Sanofi expands its social commitments, creates nonprofit unit to provide poorest countries with access to essential medicines

In an open letter, Sanofi Chief Executive Officer Paul Hudson today outlined several key projects that the company will implement to increase the...

Mar 31, 2021, 18:13 ET FDA approves Sarclisa® (isatuximab-irfc) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma

The U.S. Food and Drug Administration (FDA) has approved Sarclisa® (isatuximab-irfc) in combination with carfilzomib and dexamethasone (Kd), for the...

Nov 03, 2020, 16:14 ET Sanofi's factory of the future named world's best overall facility by International Society for Pharmaceutical Engineering

Sanofi has won the prestigious International Society for Pharmaceutical Engineering (ISPE) Overall Facility of the Year Award for its...

Oct 21, 2020, 07:00 ET Sanofi and the Parkinson's Foundation collaborate to advance the availability of free genetic testing and counseling for people with Parkinson's disease

Sanofi and the Parkinson's Foundation today announced a new research collaboration to advance the availability of genetic testing and counseling for...

Sep 09, 2020, 07:00 ET Sanofi Genzyme continues research to improve the lives of patients with multiple sclerosis, with new data presented at MSVirtual2020

Sanofi Genzyme today announced that new data from across the company's neurology portfolio will be presented at MSVirtual2020, the 8th Joint Americas ...

Sep 03, 2020, 07:00 ET Late-breaking Libtayo® (cemiplimab) pivotal data in advanced non-small cell lung cancer and basal cell carcinoma to be presented at ESMO

Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will present new, positive data for PD-1 inhibitor Libtayo® (cemiplimab) at the European...

Aug 17, 2020, 01:00 ET Sanofi to acquire Principia Biopharma

Sanofi and Principia Biopharma Inc. (NASDAQ: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune-mediated...

Jul 29, 2020, 08:00 ET Sanofi H1 2020 business EPS(1) growth of 9.2%(2) driven by transformation

Sanofi (NASDAQ: SNY; EURONEXT: SAN) Experience the interactive Multichannel News Release here:...

Jul 22, 2020, 16:30 ET Sanofi begins shipping flu vaccines in U.S. for 2020-2021 season

Sanofi Pasteur, the vaccines global business unit of Sanofi, today shipped the first of its influenza vaccine doses to health care providers in the U....

Jul 14, 2020, 07:00 ET Sanofi and MD Anderson announce strategic collaboration to accelerate oncology research and development

Sanofi and The University of Texas MD Anderson Cancer Center today announced a five-year strategic collaboration to accelerate the development of...

Jun 19, 2020, 13:51 ET FDA approves new Dupixent® (dupilumab) pre-filled pen designed to support more convenient self-administration

The U.S. Food and Drug Administration (FDA) has approved a 300 mg single-dose pre-filled pen for Dupixent® (dupilumab). The pre-filled pen is...

Jun 15, 2020, 07:00 ET Sanofi's emerging oncology pipeline highlighted at the AACR Virtual Annual Meeting II

Preclinical data for Sanofi's investigational compounds in breast, lung, multiple myeloma and other cancers will be featured at the American Academy...

Jun 14, 2020, 10:58 ET Sanofi and Sobi donate up to 500 million additional IUs of clotting factor to WFH Humanitarian Aid Program

Sanofi and Sobi™, together with the World Federation of Hemophilia (WFH) and WFH USA, today announced an extension of their support of the WFH...

May 13, 2020, 17:00 ET Sanofi to showcase oncology portfolio and innovative pipeline at ASCO20 Virtual Scientific Program

Sanofi will present data from across its oncology franchise, including portfolio and pipeline compounds, during the upcoming American Society of...

Apr 24, 2020, 07:00 ET Sanofi at forefront of fight against COVID-19 in Q1 2020

Sanofi (NASDAQ: SNY; EURONEXT: SAN) Experience the interactive Multichannel News Release here:...

Mar 16, 2020, 08:00 ET Sanofi and Regeneron begin global Kevzara® (sarilumab) clinical trial program in patients with severe COVID-19

Sanofi and Regeneron Pharmaceuticals, Inc today announced they have started a clinical program evaluating Kevzara® (sarilumab) in patients...

Mar 02, 2020, 14:42 ET FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma

The U.S. Food and Drug Administration (FDA) has approved Sarclisa® (isatuximab-irfc) in combination with pomalidomide and dexamethasone (pom-dex) for ...

Feb 28, 2020, 16:21 ET Sanofi US reaches settlement agreement to resolve allegations related to patient assistance

Sanofi U.S. today announced that it has reached an $11.85 million settlement agreement with the federal government to resolve an investigation...

Feb 24, 2020, 07:44 ET Did you know sleeping naked can help promote better skin health?

Sleeping naked can help lower your body temperature, which can help you fall asleep faster, and sleep more soundly, which in turn promotes skin...

Feb 18, 2020, 10:00 ET Sanofi joins forces with U.S. Department of Health and Human Services to advance a novel coronavirus vaccine

Sanofi (NASDAQ: SNY; EURONEXT: SAN) Pasteur, the vaccines global business unit of Sanofi, will leverage previous development work for a SARS vaccine...

Feb 06, 2020, 08:00 ET Sanofi delivers strong 2019 business EPS growth of 6.8% at CER

Sanofi (NASDAQ: SNY; EURONEXT: SAN) Q4 2019 Change Change at CER 2019 Change Change at CER IFRS net sales reported €9,608m +6.8% +4.7% €36,126m +4.8% ...

Jan 30, 2020, 07:00 ET Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency

Olipudase alfa, an investigational recombinant human acid sphingomyelinase, demonstrated positive results in two separate clinical trials evaluating...

Jan 23, 2020, 09:34 ET Sanofi Completes Acquisition of Synthorx, Inc.

Sanofi (NASDAQ: SNY; EURONEXT: SAN) announced today the successful completion of its acquisition of Synthorx, Inc. ("Synthorx") for $68 per share in...

Dec 09, 2019, 08:30 ET Sanofi awarded $226 million by US government to expand pandemic influenza preparedness

Sanofi Pasteur, the vaccines global business unit of Sanofi, has entered into an agreement with the U.S. Department of Health and Human Services...

Nov 21, 2019, 09:15 ET Pivotal data from Phase 3 study of sutimlimab in cold agglutinin disease to be presented at ASH 2019 late-breaking session

Full data from the pivotal Phase 3 CARDINAL trial evaluating the safety and efficacy of sutimlimab in people with primary cold agglutinin disease...